SIRT3 and cardiac hypertrophy: SIRT3 overexpression blocks hypertrophy both in vitro and in vivo, whereas SIRT3−/− mice exhibit enhanced susceptibility to hypertrophy [75], though it is also likely that it indirectly protects against cardiac hypertrophy by specifically controlling ROS levels.